Making better drugs for children with cancer /:
Gespeichert in:
| Körperschaft: | |
|---|---|
| Weitere Verfasser: | |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C. :
National Academies Press,
©2005.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 online resource (xiv, 42 pages) : illustrations |
| Bibliographie: | Includes bibliographical references. |
| ISBN: | 0309549256 9780309549257 9786612083327 6612083328 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocm60193363 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 050504s2005 dcua ob 000 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCL |d OCLCQ |d YDXCP |d OCLCQ |d COF |d OCLCQ |d VRC |d TUU |d OCLCQ |d ORU |d CASUM |d IDEBK |d OCLCQ |d ORU |d OCLCO |d OCLCQ |d NLGGC |d OCLCO |d OCLCQ |d EBLCP |d OCLCQ |d OCLCO |d OCLCA |d OCLCO |d TOA |d OCLCO |d AGLDB |d PIFBR |d OCLCQ |d ZCU |d OCLCQ |d MERUC |d OCLCQ |d SAV |d OCLCQ |d MERER |d WY@ |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d BUF |d OCLCO |d LUE |d OCLCO |d GILDS |d OCLCO |d OCLCF |d VNS |d OCLCO |d VTS |d ICG |d OCLCO |d INT |d VT2 |d OCLCQ |d WYU |d OCLCO |d OCLCA |d S9I |d STF |d G3B |d DKC |d OCLCQ |d OCLCO |d UX1 |d OCLCQ |d OCLCA |d AJS |d UKAHL |d OCLCO |d OCL |d OCLCQ |d OCLCO |d OCLCQ |d OCLCL | ||
| 016 | 7 | |a 101254456 |2 DNLM | |
| 019 | |a 642458791 |a 666928317 |a 923274427 |a 1055332040 |a 1064767737 |a 1081212734 |a 1152992446 | ||
| 020 | |a 0309549256 |q (electronic bk.) | ||
| 020 | |a 9780309549257 |q (electronic bk.) | ||
| 020 | |a 9786612083327 | ||
| 020 | |a 6612083328 | ||
| 020 | |z 0309096081 |q (pbk.) | ||
| 020 | |z 9780309096089 |q (pbk.) | ||
| 035 | |a (OCoLC)60193363 |z (OCoLC)642458791 |z (OCoLC)666928317 |z (OCoLC)923274427 |z (OCoLC)1055332040 |z (OCoLC)1064767737 |z (OCoLC)1081212734 |z (OCoLC)1152992446 | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a RA401.5 |b .N38 2005eb | |
| 060 | 4 | |a 2005 J-394 | |
| 060 | 4 | |a QZ 275 |b M235 2005 | |
| 072 | 7 | |a MED |x 023000 |2 bisacsh | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 072 | 7 | |a MED |x 072000 |2 bisacsh | |
| 072 | 7 | |a MED |x 058170 |2 bisacsh | |
| 082 | 7 | |a 615.19 |2 22 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Making better drugs for children with cancer / |c Committee on Shortening the Time Line for New Cancer Treatments, National Cancer Policy Board ; Peter C. Adamson [and others], editors ; Institute of Medicine and National Research Council of the National Academies. |
| 260 | |a Washington, D.C. : |b National Academies Press, |c ©2005. | ||
| 300 | |a 1 online resource (xiv, 42 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file | ||
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | |a Childhood cancers: Background -- Agents in use and in testing for children with cancer -- The existing capacity for developing new agents specifically for childhood cancers -- Putting the pieces together -- Delays in testing approved agents in children -- The need to prioritize agents for testing in children with cancer -- Testing and labeling of drugs for pediatric use. | |
| 588 | 0 | |a Print version record. | |
| 650 | 0 | |a Drug approval |z United States. | |
| 650 | 0 | |a Cancer in children |x Chemotherapy. | |
| 650 | 0 | |a Children. |0 http://id.loc.gov/authorities/subjects/sh85023418 | |
| 650 | 1 | 2 | |a Neoplasms |x drug therapy |
| 650 | 2 | 2 | |a Antineoplastic Agents |
| 650 | 2 | 2 | |a Child |
| 650 | 2 | 2 | |a Clinical Trials |
| 650 | 2 | 2 | |a Drug Approval |
| 650 | 2 | 2 | |a Neoplasms |x epidemiology |
| 651 | 2 | |a United States | |
| 650 | 6 | |a Médicaments |x Autorisation de mise sur le marché |z États-Unis. | |
| 650 | 6 | |a Cancer chez l'enfant |x Chimiothérapie. | |
| 650 | 6 | |a Anticancéreux. | |
| 650 | 6 | |a Enfants. | |
| 650 | 7 | |a children (people by age group) |2 aat | |
| 650 | 7 | |a MEDICAL |x Drug Guides. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacy. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Nursing |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Children |2 fast | |
| 650 | 7 | |a Drug approval |2 fast | |
| 651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 700 | 1 | |a Adamson, Peter C. |0 http://id.loc.gov/authorities/names/n2005183486 | |
| 710 | 2 | |a National Cancer Policy Board (U.S.). |b Committee on Shortening the Time Line for New Cancer Treatments. |0 http://id.loc.gov/authorities/names/n2005183487 | |
| 758 | |i has work: |a Making better drugs for children with cancer (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFwdgDcVXFDb3mb884K9j3 |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Making better drugs for children with cancer. |d Washington, D.C. : National Academies Press, ©2005 |z 0309096081 |w (DLC) 2005282528 |w (OCoLC)60504477 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=131249 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36616997 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL3377934 | ||
| 938 | |a EBSCOhost |b EBSC |n 131249 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 208332 | ||
| 938 | |a YBP Library Services |b YANK |n 2293515 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocm60193363 |
|---|---|
| _version_ | 1816881627186331648 |
| adam_text | |
| any_adam_object | |
| author2 | Adamson, Peter C. |
| author2_role | |
| author2_variant | p c a pc pca |
| author_GND | http://id.loc.gov/authorities/names/n2005183486 |
| author_corporate | National Cancer Policy Board (U.S.). Committee on Shortening the Time Line for New Cancer Treatments |
| author_corporate_role | |
| author_facet | Adamson, Peter C. National Cancer Policy Board (U.S.). Committee on Shortening the Time Line for New Cancer Treatments |
| author_sort | Adamson, Peter C. |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RA401 |
| callnumber-raw | RA401.5 .N38 2005eb |
| callnumber-search | RA401.5 .N38 2005eb |
| callnumber-sort | RA 3401.5 N38 42005EB |
| callnumber-subject | RA - Public Medicine |
| collection | ZDB-4-EBA |
| contents | Childhood cancers: Background -- Agents in use and in testing for children with cancer -- The existing capacity for developing new agents specifically for childhood cancers -- Putting the pieces together -- Delays in testing approved agents in children -- The need to prioritize agents for testing in children with cancer -- Testing and labeling of drugs for pediatric use. |
| ctrlnum | (OCoLC)60193363 |
| dewey-full | 615.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.19 |
| dewey-search | 615.19 |
| dewey-sort | 3615.19 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04655cam a2200853 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocm60193363 </controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu|||unuuu</controlfield><controlfield tag="008">050504s2005 dcua ob 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">COF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VRC</subfield><subfield code="d">TUU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">ORU</subfield><subfield code="d">CASUM</subfield><subfield code="d">IDEBK</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">ORU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">TOA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AGLDB</subfield><subfield code="d">PIFBR</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">ZCU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">SAV</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MERER</subfield><subfield code="d">WY@</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">BUF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">LUE</subfield><subfield code="d">OCLCO</subfield><subfield code="d">GILDS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCF</subfield><subfield code="d">VNS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">VTS</subfield><subfield code="d">ICG</subfield><subfield code="d">OCLCO</subfield><subfield code="d">INT</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">S9I</subfield><subfield code="d">STF</subfield><subfield code="d">G3B</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">UX1</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">AJS</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101254456</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">642458791</subfield><subfield code="a">666928317</subfield><subfield code="a">923274427</subfield><subfield code="a">1055332040</subfield><subfield code="a">1064767737</subfield><subfield code="a">1081212734</subfield><subfield code="a">1152992446</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309549256</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309549257</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9786612083327</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">6612083328</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309096081</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309096089</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)60193363</subfield><subfield code="z">(OCoLC)642458791</subfield><subfield code="z">(OCoLC)666928317</subfield><subfield code="z">(OCoLC)923274427</subfield><subfield code="z">(OCoLC)1055332040</subfield><subfield code="z">(OCoLC)1064767737</subfield><subfield code="z">(OCoLC)1081212734</subfield><subfield code="z">(OCoLC)1152992446</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">n-us---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RA401.5</subfield><subfield code="b">.N38 2005eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2005 J-394</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QZ 275</subfield><subfield code="b">M235 2005</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">023000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">071000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">072000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">058170</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615.19</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Making better drugs for children with cancer /</subfield><subfield code="c">Committee on Shortening the Time Line for New Cancer Treatments, National Cancer Policy Board ; Peter C. Adamson [and others], editors ; Institute of Medicine and National Research Council of the National Academies.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, D.C. :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">©2005.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xiv, 42 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">data file</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Childhood cancers: Background -- Agents in use and in testing for children with cancer -- The existing capacity for developing new agents specifically for childhood cancers -- Putting the pieces together -- Delays in testing approved agents in children -- The need to prioritize agents for testing in children with cancer -- Testing and labeling of drugs for pediatric use.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug approval</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer in children</subfield><subfield code="x">Chemotherapy.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Children.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85023418</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Antineoplastic Agents</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Child</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Clinical Trials</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Drug Approval</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Neoplasms</subfield><subfield code="x">epidemiology</subfield></datafield><datafield tag="651" ind1=" " ind2="2"><subfield code="a">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments</subfield><subfield code="x">Autorisation de mise sur le marché</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cancer chez l'enfant</subfield><subfield code="x">Chimiothérapie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Anticancéreux.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Enfants.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">children (people by age group)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Drug Guides.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacy.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Nursing</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Children</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug approval</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Adamson, Peter C.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2005183486</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Cancer Policy Board (U.S.).</subfield><subfield code="b">Committee on Shortening the Time Line for New Cancer Treatments.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2005183487</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Making better drugs for children with cancer (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFwdgDcVXFDb3mb884K9j3</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Making better drugs for children with cancer.</subfield><subfield code="d">Washington, D.C. : National Academies Press, ©2005</subfield><subfield code="z">0309096081</subfield><subfield code="w">(DLC) 2005282528</subfield><subfield code="w">(OCoLC)60504477</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=131249</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36616997</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBL - Ebook Library</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3377934</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">131249</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">208332</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">2293515</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| geographic | United States United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq |
| geographic_facet | United States |
| id | ZDB-4-EBA-ocm60193363 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:15:43Z |
| institution | BVB |
| institution_GND | http://id.loc.gov/authorities/names/n2005183487 |
| isbn | 0309549256 9780309549257 9786612083327 6612083328 |
| language | English |
| oclc_num | 60193363 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (xiv, 42 pages) : illustrations |
| psigel | ZDB-4-EBA |
| publishDate | 2005 |
| publishDateSearch | 2005 |
| publishDateSort | 2005 |
| publisher | National Academies Press, |
| record_format | marc |
| spelling | Making better drugs for children with cancer / Committee on Shortening the Time Line for New Cancer Treatments, National Cancer Policy Board ; Peter C. Adamson [and others], editors ; Institute of Medicine and National Research Council of the National Academies. Washington, D.C. : National Academies Press, ©2005. 1 online resource (xiv, 42 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier data file Includes bibliographical references. Childhood cancers: Background -- Agents in use and in testing for children with cancer -- The existing capacity for developing new agents specifically for childhood cancers -- Putting the pieces together -- Delays in testing approved agents in children -- The need to prioritize agents for testing in children with cancer -- Testing and labeling of drugs for pediatric use. Print version record. Drug approval United States. Cancer in children Chemotherapy. Children. http://id.loc.gov/authorities/subjects/sh85023418 Neoplasms drug therapy Antineoplastic Agents Child Clinical Trials Drug Approval Neoplasms epidemiology United States Médicaments Autorisation de mise sur le marché États-Unis. Cancer chez l'enfant Chimiothérapie. Anticancéreux. Enfants. children (people by age group) aat MEDICAL Drug Guides. bisacsh MEDICAL Pharmacology. bisacsh MEDICAL Pharmacy. bisacsh MEDICAL Nursing Pharmacology. bisacsh Children fast Drug approval fast United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq Adamson, Peter C. http://id.loc.gov/authorities/names/n2005183486 National Cancer Policy Board (U.S.). Committee on Shortening the Time Line for New Cancer Treatments. http://id.loc.gov/authorities/names/n2005183487 has work: Making better drugs for children with cancer (Text) https://id.oclc.org/worldcat/entity/E39PCFwdgDcVXFDb3mb884K9j3 https://id.oclc.org/worldcat/ontology/hasWork Print version: Making better drugs for children with cancer. Washington, D.C. : National Academies Press, ©2005 0309096081 (DLC) 2005282528 (OCoLC)60504477 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=131249 Volltext |
| spellingShingle | Making better drugs for children with cancer / Childhood cancers: Background -- Agents in use and in testing for children with cancer -- The existing capacity for developing new agents specifically for childhood cancers -- Putting the pieces together -- Delays in testing approved agents in children -- The need to prioritize agents for testing in children with cancer -- Testing and labeling of drugs for pediatric use. Drug approval United States. Cancer in children Chemotherapy. Children. http://id.loc.gov/authorities/subjects/sh85023418 Neoplasms drug therapy Antineoplastic Agents Child Clinical Trials Drug Approval Neoplasms epidemiology Médicaments Autorisation de mise sur le marché États-Unis. Cancer chez l'enfant Chimiothérapie. Anticancéreux. Enfants. children (people by age group) aat MEDICAL Drug Guides. bisacsh MEDICAL Pharmacology. bisacsh MEDICAL Pharmacy. bisacsh MEDICAL Nursing Pharmacology. bisacsh Children fast Drug approval fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85023418 |
| title | Making better drugs for children with cancer / |
| title_auth | Making better drugs for children with cancer / |
| title_exact_search | Making better drugs for children with cancer / |
| title_full | Making better drugs for children with cancer / Committee on Shortening the Time Line for New Cancer Treatments, National Cancer Policy Board ; Peter C. Adamson [and others], editors ; Institute of Medicine and National Research Council of the National Academies. |
| title_fullStr | Making better drugs for children with cancer / Committee on Shortening the Time Line for New Cancer Treatments, National Cancer Policy Board ; Peter C. Adamson [and others], editors ; Institute of Medicine and National Research Council of the National Academies. |
| title_full_unstemmed | Making better drugs for children with cancer / Committee on Shortening the Time Line for New Cancer Treatments, National Cancer Policy Board ; Peter C. Adamson [and others], editors ; Institute of Medicine and National Research Council of the National Academies. |
| title_short | Making better drugs for children with cancer / |
| title_sort | making better drugs for children with cancer |
| topic | Drug approval United States. Cancer in children Chemotherapy. Children. http://id.loc.gov/authorities/subjects/sh85023418 Neoplasms drug therapy Antineoplastic Agents Child Clinical Trials Drug Approval Neoplasms epidemiology Médicaments Autorisation de mise sur le marché États-Unis. Cancer chez l'enfant Chimiothérapie. Anticancéreux. Enfants. children (people by age group) aat MEDICAL Drug Guides. bisacsh MEDICAL Pharmacology. bisacsh MEDICAL Pharmacy. bisacsh MEDICAL Nursing Pharmacology. bisacsh Children fast Drug approval fast |
| topic_facet | Drug approval United States. Cancer in children Chemotherapy. Children. Neoplasms drug therapy Antineoplastic Agents Child Clinical Trials Drug Approval Neoplasms epidemiology United States Médicaments Autorisation de mise sur le marché États-Unis. Cancer chez l'enfant Chimiothérapie. Anticancéreux. Enfants. children (people by age group) MEDICAL Drug Guides. MEDICAL Pharmacology. MEDICAL Pharmacy. MEDICAL Nursing Pharmacology. Children Drug approval |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=131249 |
| work_keys_str_mv | AT adamsonpeterc makingbetterdrugsforchildrenwithcancer AT nationalcancerpolicyboarduscommitteeonshorteningthetimelinefornewcancertreatments makingbetterdrugsforchildrenwithcancer |